CN111840225B - 一种用于治疗青光眼的滴眼剂及其制备方法 - Google Patents
一种用于治疗青光眼的滴眼剂及其制备方法 Download PDFInfo
- Publication number
- CN111840225B CN111840225B CN202010806420.4A CN202010806420A CN111840225B CN 111840225 B CN111840225 B CN 111840225B CN 202010806420 A CN202010806420 A CN 202010806420A CN 111840225 B CN111840225 B CN 111840225B
- Authority
- CN
- China
- Prior art keywords
- tafluprost
- stabilizer
- injection
- water
- polylysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例 | 过滤前含量 | 过滤后含量 |
实施例1 | 99.90% | 99.89% |
实施例2 | 99.86% | 99.85% |
实施例3 | 99.87% | 99.85% |
实施例4 | 99.92% | 99.90% |
实施例5 | 99.95% | 99.92% |
对比例1 | 99.78% | 97.72% |
对比例2 | 99.89% | 96.93% |
对比例3 | 99.92% | 97.83% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010806420.4A CN111840225B (zh) | 2020-08-12 | 2020-08-12 | 一种用于治疗青光眼的滴眼剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010806420.4A CN111840225B (zh) | 2020-08-12 | 2020-08-12 | 一种用于治疗青光眼的滴眼剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111840225A CN111840225A (zh) | 2020-10-30 |
CN111840225B true CN111840225B (zh) | 2021-09-14 |
Family
ID=72972763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010806420.4A Expired - Fee Related CN111840225B (zh) | 2020-08-12 | 2020-08-12 | 一种用于治疗青光眼的滴眼剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111840225B (zh) |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020320A (ja) * | 2000-06-30 | 2002-01-23 | Santen Pharmaceut Co Ltd | 点眼液用防腐剤 |
CN102083413A (zh) * | 2008-05-30 | 2011-06-01 | 参天制药株式会社 | 用于治疗高眼压和青光眼的方法和组合物 |
CN102143753A (zh) * | 2008-09-04 | 2011-08-03 | 参天制药株式会社 | 含有15,15-二氟***素F2α衍生物作为有效成分的毛发生长促进剂 |
CN102341093A (zh) * | 2009-03-04 | 2012-02-01 | 诺瓦加利制药公司 | 含***素的阴离子水包油型乳液和其用途 |
CN102421425A (zh) * | 2009-05-14 | 2012-04-18 | 乌尔萨法姆药物两合公司 | 用于治疗青光眼的不含磷酸盐的药物组合物 |
KR20140055205A (ko) * | 2012-10-30 | 2014-05-09 | 주식회사 파마리서치프로덕트 | 폴리데옥시리보뉴클레오타이드 함유 점성 점안제 조성물 및 이의 제조방법 |
WO2014192068A1 (ja) * | 2013-05-27 | 2014-12-04 | 株式会社メニコン | 抗アカントアメーバ用組成物及び該抗アカントアメーバ用組成物を含有する眼科用剤 |
CN104622798A (zh) * | 2014-12-05 | 2015-05-20 | 广东东阳光药业有限公司 | 一种含有他氟前列素的滴眼液及其制备方法 |
CN105012231A (zh) * | 2014-04-30 | 2015-11-04 | 四川科伦药物研究院有限公司 | 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法 |
WO2015193677A1 (en) * | 2014-06-20 | 2015-12-23 | Coopervision International Holding Company, Lp | Ophthalmic composition for the treatment of ocular infection |
CN105380901A (zh) * | 2015-11-18 | 2016-03-09 | 侯宇华 | 一种他氟前列素滴眼剂及其制备方法 |
CN106265701A (zh) * | 2016-08-05 | 2017-01-04 | 西南大学 | 一种温敏型凝胶滴眼剂及其制备方法和应用 |
WO2017083619A1 (en) * | 2015-11-13 | 2017-05-18 | The University Of Massachusetts | Bifunctional molecules containing peg for use in inhibiting cataracts and presbyopia |
JP2017197525A (ja) * | 2016-04-22 | 2017-11-02 | ロート製薬株式会社 | 水性組成物 |
CN109172580A (zh) * | 2018-09-06 | 2019-01-11 | 中山万汉制药有限公司 | 包含***素衍生物的组合物以及包含该组合物的眼用液体制剂 |
CN110013464A (zh) * | 2018-01-09 | 2019-07-16 | 中科艾玛科技成都有限公司 | 一种滴眼液及其制备方法 |
CN110711175A (zh) * | 2019-11-12 | 2020-01-21 | 南京华盖制药有限公司 | 一种他氟前列素滴眼剂及其制备方法 |
-
2020
- 2020-08-12 CN CN202010806420.4A patent/CN111840225B/zh not_active Expired - Fee Related
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020320A (ja) * | 2000-06-30 | 2002-01-23 | Santen Pharmaceut Co Ltd | 点眼液用防腐剤 |
CN102083413A (zh) * | 2008-05-30 | 2011-06-01 | 参天制药株式会社 | 用于治疗高眼压和青光眼的方法和组合物 |
CN102143753A (zh) * | 2008-09-04 | 2011-08-03 | 参天制药株式会社 | 含有15,15-二氟***素F2α衍生物作为有效成分的毛发生长促进剂 |
CN102341093A (zh) * | 2009-03-04 | 2012-02-01 | 诺瓦加利制药公司 | 含***素的阴离子水包油型乳液和其用途 |
CN102421425A (zh) * | 2009-05-14 | 2012-04-18 | 乌尔萨法姆药物两合公司 | 用于治疗青光眼的不含磷酸盐的药物组合物 |
KR20140055205A (ko) * | 2012-10-30 | 2014-05-09 | 주식회사 파마리서치프로덕트 | 폴리데옥시리보뉴클레오타이드 함유 점성 점안제 조성물 및 이의 제조방법 |
WO2014192068A1 (ja) * | 2013-05-27 | 2014-12-04 | 株式会社メニコン | 抗アカントアメーバ用組成物及び該抗アカントアメーバ用組成物を含有する眼科用剤 |
CN105012231A (zh) * | 2014-04-30 | 2015-11-04 | 四川科伦药物研究院有限公司 | 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法 |
WO2015193677A1 (en) * | 2014-06-20 | 2015-12-23 | Coopervision International Holding Company, Lp | Ophthalmic composition for the treatment of ocular infection |
CN104622798A (zh) * | 2014-12-05 | 2015-05-20 | 广东东阳光药业有限公司 | 一种含有他氟前列素的滴眼液及其制备方法 |
WO2017083619A1 (en) * | 2015-11-13 | 2017-05-18 | The University Of Massachusetts | Bifunctional molecules containing peg for use in inhibiting cataracts and presbyopia |
CN105380901A (zh) * | 2015-11-18 | 2016-03-09 | 侯宇华 | 一种他氟前列素滴眼剂及其制备方法 |
JP2017197525A (ja) * | 2016-04-22 | 2017-11-02 | ロート製薬株式会社 | 水性組成物 |
CN106265701A (zh) * | 2016-08-05 | 2017-01-04 | 西南大学 | 一种温敏型凝胶滴眼剂及其制备方法和应用 |
CN110013464A (zh) * | 2018-01-09 | 2019-07-16 | 中科艾玛科技成都有限公司 | 一种滴眼液及其制备方法 |
CN109172580A (zh) * | 2018-09-06 | 2019-01-11 | 中山万汉制药有限公司 | 包含***素衍生物的组合物以及包含该组合物的眼用液体制剂 |
CN110711175A (zh) * | 2019-11-12 | 2020-01-21 | 南京华盖制药有限公司 | 一种他氟前列素滴眼剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
Topical Ocular Delivery of NSAIDs;Munish Ahuja;《AAPS J》;20080425;第10卷(第2期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN111840225A (zh) | 2020-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2763654B1 (en) | Ophthtalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid | |
US8901131B2 (en) | Gatifloxacin-containing ophthalmic gel and preparation method thereof | |
WO2020063320A1 (zh) | 一种提高低浓度阿托品眼用制剂稳定性的方法 | |
CN105380901A (zh) | 一种他氟前列素滴眼剂及其制备方法 | |
WO2021017475A1 (zh) | 一种含有环孢素的眼用药物组合物、其制备方法及用途 | |
CN106913518A (zh) | 一种前体型非甾体抗炎眼用凝胶及其制备方法 | |
CN111840225B (zh) | 一种用于治疗青光眼的滴眼剂及其制备方法 | |
CN106880590A (zh) | 一种前体型非甾体抗炎滴眼液及其制备方法 | |
KR102273481B1 (ko) | 사이클로스포린 및 멘톨 함유 나노 에멀젼 점안 조성물 및 그의 제조 방법 | |
EP3307241B1 (en) | Drippable ophthalmic bimatoprost gel | |
CN102716074B (zh) | 一种贝美前列素滴眼剂及其制备方法 | |
CN113786380A (zh) | 一种硝酸毛果芸香碱眼用凝胶及其制备方法 | |
CN110711175A (zh) | 一种他氟前列素滴眼剂及其制备方法 | |
CN111450044B (zh) | 一种含有灯盏乙素的眼用制剂、制备方法及其应用 | |
CN115487139B (zh) | 一种葛根素结冷胶离子型原位凝胶滴眼液及制备方法 | |
CA3041626C (en) | Ophthalmic composition for lowering intraocular pressure | |
CN115212200B (zh) | 用于治疗糖尿病并发症的含葛根素的复方制剂及其制备方法 | |
CN116473918A (zh) | 一种酒石酸溴莫尼定滴眼液及其制备方法 | |
CN116421555A (zh) | 一种酒石酸溴莫尼定滴眼液及其制备方法 | |
CN108853013B (zh) | 一种滴眼液及其制备方法和应用 | |
CN111084758A (zh) | 盐酸多佐胺滴眼液及其制备方法 | |
CN115429800A (zh) | 稳定的低浓度阿托品眼用制剂及其制备方法与用途 | |
CN106619492A (zh) | 一种前体型非甾体抗炎眼膏及其制备方法 | |
CN118078825A (zh) | 一种包含阿托品的眼用药物组合物、制剂及制备方法 | |
CN111358771A (zh) | 一种硫酸阿托品眼用膜剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Lina Inventor after: Wang Xin Inventor before: Wang Xin |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210827 Address after: 266300 Jiaozhou People's Hospital, No. 88 Guangzhou North Road, Qingdao City, Shandong Province Applicant after: Chen Lina Address before: 325000 No. 80 Xicheng Road, Lucheng District, Wenzhou City, Zhejiang Province Applicant before: Wang Xin |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210914 |
|
CF01 | Termination of patent right due to non-payment of annual fee |